Barclays PLC Has $3.63 Million Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Barclays PLC boosted its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 6.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 311,632 shares of the company’s stock after buying an additional 18,837 shares during the period. Barclays PLC owned approximately 0.31% […]
Barclays PLC boosted its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 6.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 311,632 shares of the company’s stock after buying an additional 18,837 shares during the period. Barclays PLC owned approximately 0.31% […]
